Il Percorso Diagnostico Terapeutico Assistenziale nella Sclerosi Multipla: impatto sull’organizzazione, sulla qualita e sui costi di gestione della malattia

Autori: Antonio Bertolotto, Giorgio L. Colombo

Multiple sclerosis (MS) is a serious disease of the central nervous system affecting pa- tients in complex and multiform ways. The various treatments for SM and the different functional approach to its degree of severity require greater attention in terms of patient management. The diagnostic-therapeutic pathway known as PDTA (Percorso Diagnos- tico Terapeutico Assistenziale) is an instrument used to outline the entire procedure a patient undergoes within a health care facility.

The objective of this work is to define the potentialities of using the PDTA in our health care services, and to assess the application field of PDTA in the diagnosis and treatment of SC. In fact, through an approach by processes, inherent in the structure of a PDTA, it is possible to evaluate the congruence of the activities performed relative to the objectives, the reference guidelines, and the available resources. Accordingly, to favour the adoption of a PDTA for SC appears to be a relevant necessity to stimulate the observation of the actions to take with regard to the case to treat, and to coordinate, within the best possible time sequence, the intervention and the contributions of the individuals involved in managing the patient. The use of the PDTA leads to a continuing “benchmarking” within the different health care facilities by measuring the activities and outcomes through health, economic and standard cost indicators.


Sclerosi Multipla (SM), Multiple sclerosis (MS).


Visualizzazioni Totali: 122